Invesco Exchange-Traded Self-Indexed Fund Trust has released its latest financial results, showcasing a robust total asset figure of over $3.26 billion. This significant amount underlines the trust's stability and ongoing appeal in the investment sector, particularly in the exchange-traded fund (ETF) market.
The filing, dated October 30, 2026, provides insights into the fund's financial health as of August 31, 2026. It highlights the trust's total liabilities at approximately $295.5 million, resulting in net assets of around $2.97 billion. This positive net asset figure indicates a healthy balance sheet and affirms the trust's position in the competitive investment landscape.
Background
Invesco Exchange-Traded Self-Indexed Fund Trust, incorporated in Delaware, operates under the investment entity type. The trust previously operated under the name PowerShares Exchange-Traded Self-Indexed Fund Trust. The recent filing is part of a series of reports submitted on October 30, 2026, showcasing the trust's financial performance and investment strategies.
What the Filing Says
The NPORT-P filing reveals that the Invesco BulletShares 2029 Corporate Bond ETF is a key component of the trust's offerings. The report indicates, "The total assets amount to $3,263,381,011.19, with total liabilities of $295,542,022.39, leading to net assets of $2,967,838,988.80." This data emphasizes the trust's strong financial footing.
Impact
The filing's details may influence investors and stakeholders within the investment sector, particularly those focused on exchange-traded funds. The trust's performance could set benchmarks for competitors and affect market dynamics as firms strive to attract similar asset levels. Key competitors in the ETF space may include firms that also manage corporate bond ETFs.
What's Next
The filing does not specify any immediate next steps or actions required from the trust or its stakeholders. However, continued monitoring of the trust's performance and future filings will be essential for investors and analysts.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






